Clinical trials
Phase 3 Primary Myelofibrosis trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 4 |
| Completed | 4 |
| Terminated | 3 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| AbbVie | 2 |
| Celgene | 2 |
| Incyte Corporation | 2 |
| PharmaEssentia | 1 |
| Sierra Oncology LLC - a GSK company | 1 |
| Swedish Orphan Biovitrum | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 13 |
| Myeloproliferative Disorders | 4 |
| Anemia | 3 |
| Neoplasms | 2 |
| Blood Platelet Disorders | 1 |
| Bone Marrow Diseases | 1 |
| Hematologic Diseases | 1 |
| Hemorrhagic Disorders | 1 |
| Splenomegaly | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.